Using Smudge Cells on Routine Blood Smears to Predict Clinical Outcome in Chronic Lymphocytic Leukemia: A Universally Available Prognostic Test
- 30 April 2007
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 82 (4), 449-453
- https://doi.org/10.4065/82.4.449
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Proteomic Analysis of Chronic Lymphocytic Leukemia Cells Identifies Vimentin as a Novel Prognostic Factor for Aggressive Disease.Blood, 2005
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2004
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2003
- Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemiaBritish Journal of Haematology, 2001
- Rigidity of Circulating Lymphocytes Is Primarily Conferred by Vimentin Intermediate FilamentsPublished by The American Association of Immunologists ,2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic LeukemiaBlood, 1999
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999
- Incidence of Chronic Lymphocytic Leukemia in Olmsted County, Minnesota, 1935 Through 1989, With Emphasis on Changes in Initial Stage at DiagnosisMayo Clinic Proceedings, 1994